There were 22, 23, 1, and 1 prospectively detected ovarian cancer cases included in the survival analyses in path_MLH1, path_MSH2, path_MSH6, and path_PMS2 heterozygotes, respectively. This evidence concerns the gene MSH2 and ovarian carcinoma.